Speech-Language Pathologists in Austell, GA Accepting Medicare

7 Speech-Language Pathologists found. Showing 1 - 7

Parizah Knowles, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3875 Austell Rd Ste 201, Austell, GA 30106 Phone: 800-381-2195    Fax: 888-381-0822

Quality Of Life Therapy Associates Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7483 Silver Arrow Trl, Austell, GA 30168 Phone: 470-377-3980

Mrs. Tonya Renee Baldwin Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4229 Brass Trl., Austell, GA 30106 Phone: 770-255-8861

Randi Pomycala, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 770-372-4000

Mrs. Taunisha Dawn Summerville Mcneill, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2331 Greenside Dr, Austell, GA 30106 Phone: 770-941-6770    Fax: 678-317-0890

Ryan Townsend Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 E West Connector, Austell, GA 30106 Phone: 770-628-1234

Bridget Ann Barrett, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1700 Mulkey Rd, Austell, GA 30106 Phone: 770-941-5750

News Archive

Warming climate may increase risk from Chagas disease

In the spring of 1835, Charles Darwin was bitten in Argentina by a "great wingless black bug," he wrote in his diary. "It is most disgusting to feel soft wingless insects, about an inch long, crawling over one's body," Darwin wrote, "before sucking they are quite thin, but afterwards round & bloated with blood."

Griffith researcher awarded $1.85m grant to accelerate diagnosis, treatment for CFS

Providing increased services for Chronic Fatigue Syndrome sufferers will be the focus of Griffith research following the award of a $1.85m grant to one of Australia's foremost authorities on the condition.

FDA approves Iroko Pharmaceuticals' TIVORBEX capsules

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved TIVORBEX™ (indomethacin) capsules, a nonsteroidal anti-inflammatory drug (NSAID), at 20 mg and 40 mg doses for the treatment of mild to moderate acute pain in adults.

Susceptibility to pain is affected by premature birth and also genetics

Scientists in US and UK laboratories have made key discoveries into the elusive nature of pain in children and adults. The results, presented at the Forum of European Neurosciences Monday will help guide the future management and treatment of pain.

Study: Low-calorie diet causes different metabolic effects in women than in men

A low-calorie diet causes different metabolic effects in women than in men, a new Diabetes, Obesity and Metabolism study suggests.

Read more Medical News

› Verified 8 days ago